Previous close | 66.53 |
Open | 66.88 |
Bid | 64.87 x 200 |
Ask | 65.03 x 100 |
Day's range | 64.92 - 66.88 |
52-week range | 45.50 - 84.89 |
Volume | |
Avg. volume | 961,857 |
Market cap | 6.862B |
Beta (5Y monthly) | 1.00 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) investors will be delighted, with the company turning in some strong...
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript May 7, 2024 Intra-Cellular Therapies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies’ First Quarter 2024 Earnings Conference Call. At […]
Explore key financial achievements and strategic directions from Intra-Cellular Therapies' first quarter of 2024, including a significant revenue increase and promising drug development updates.